Found: 23
Select item for more details and to access through your institution.
Drug development for cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2021, v. 56, p. S10, doi. 10.1002/ppul.25075
- By:
- Publication type:
- Article
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF).
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 2, p. 220, doi. 10.3390/ph16020220
- By:
- Publication type:
- Article
Early-Life Height Attainment in Cystic Fibrosis Is Associated with Pulmonary Function at Age 6 Years.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Inflammation in cystic fibrosis: An update.
- Published in:
- Pediatric Pulmonology, 2018, v. 53, p. S30, doi. 10.1002/ppul.24129
- By:
- Publication type:
- Article
Inflammation and its genesis in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2015, v. 50, p. S39, doi. 10.1002/ppul.23242
- By:
- Publication type:
- Article
Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection.
- Published in:
- Pediatric Pulmonology, 2014, v. 49, n. 7, p. 650, doi. 10.1002/ppul.22890
- By:
- Publication type:
- Article
Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.
- Published in:
- Nutrition in Clinical Practice, 2015, v. 30, n. 6, p. 838, doi. 10.1177/0884533615589991
- By:
- Publication type:
- Article
Official American Thoracic Society Technical Standards: Flexible Airway Endoscopy in Children.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. 1066, doi. 10.1164/rccm.201503-0474ST
- By:
- Publication type:
- Article
An Official American Thoracic Society Technical Standards: Flexible Airway Endoscopy in Children.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. E1, doi. 10.1164/rccm.201503-0474st
- By:
- Publication type:
- Article
State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
- Published in:
- Respiratory Research, 2003, v. 4, p. 1
- By:
- Publication type:
- Article
Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2003, v. 168, n. 12, p. 1471, doi. 10.1164/rccm.200306-731OC
- By:
- Publication type:
- Article
Somatic cell hemoglobin modulates nitrogen oxide metabolism in the human airway epithelium.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94782-5
- By:
- Publication type:
- Article
Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor.
- Published in:
- International Journal of Neonatal Screening (IJNS), 2023, v. 9, n. 1, p. 10, doi. 10.3390/ijns9010010
- By:
- Publication type:
- Article
Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.
- Published in:
- Chronic Respiratory Disease, 2017, v. 14, n. 4, p. 392, doi. 10.1177/1479972317694621
- By:
- Publication type:
- Article
Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of Treatment of Cystic Fibrosis Pulmonary Exacerbations on Systemic Inflammation.
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 5, p. 708, doi. 10.1513/AnnalsATS.201410-493OC
- By:
- Publication type:
- Article
Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Antibiotic Management of Lung Infections in Cystic Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2014, v. 11, n. 8, p. 1298, doi. 10.1513/AnnalsATS.201405-203AS
- By:
- Publication type:
- Article
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Antibiotic Management of Lung Infections in Cystic Fibrosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Azithromycin May Antagonize Inhaled Tobramycin When Targeting Pseudomonas aeruginosa in Cystic Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2014, v. 11, n. 3, p. 342, doi. 10.1513/AnnalsATS.201310-352OC
- By:
- Publication type:
- Article
Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Role of Inhaled Corticosteroids in the Management of Cystic Fibrosis.
- Published in:
- Pediatric Drugs, 2009, v. 11, n. 2, p. 101, doi. 10.2165/00148581-200911020-00002
- By:
- Publication type:
- Article